Study Progression on Non-small Cell Lung Cancer with EGFR Mutation 
Treated by Immune Checkpoint Inhibitors

類似資料

• Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy
  著者:: Rilan Bai, 等
  出版事項: (2022-05-01)
• Role of EGFR Mutation Status in Patients with Stage III Non-squamous Non-small Cell Lung Cancer Treated with Chemoradiotherapy
  著者:: Fuhai LI, 等
  出版事項: (2011-09-01)
• Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of 
Small Cell Lung Cancer
  著者:: Benlin HUANG, 等
  出版事項: (2019-04-01)
• Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
  著者:: Bai, Rilan, 等
  出版事項: (2020)
• Clinical Features of EGFR Double Mutation in Non-small Cell Lung Cancer
  著者:: Mengyao WANG, 等
  出版事項: (2018-08-01)